reported both pre-treatment and dynamic changes of decreasing plasma cfRNA PD-L1 by RT-PCR were associated with ICI treatment response rate in 52 metastatic NSCLC patients [18]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.